{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:24:30Z","timestamp":1794360270294,"version":"4.9.0"},"reference-count":114,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"unspecified","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2024,2,16]]},"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>The <jats:underline>EXA<\/jats:underline>cerbations of <jats:underline>C<\/jats:underline>hronic obstructive lung disease (COPD) and their <jats:underline>O<\/jats:underline>utcome<jats:underline>S<\/jats:underline> (EXACOS) International Study aimed to quantify the rate of severe exacerbations and examine healthcare resource utilisation (HCRU) and clinical outcomes in patients with COPD from low-income and middle-income countries.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>EXACOS International was an observational, cross-sectional study with retrospective data collection from medical records for a period of up to 5 years. Data were collected from 12 countries: Argentina, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Guatemala, Hong Kong, Mexico, Panama, Russia and Taiwan. The study population comprised patients \u226540 years of age with COPD. Outcomes\/variables included the prevalence of severe exacerbations, the annual rate of severe exacerbations and time between severe exacerbations; change in lung function over time (measured by the forced expiratory volume in 1\u2009s (FEV<jats:sub>1<\/jats:sub>)); peripheral blood eosinophil counts (BECs) and the prevalence of comorbidities; treatment patterns; and HCRU.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 1702 patients were included in the study. The study population had a mean age of 69.7 years, with 69.4% males, and a mean body mass index of 26.4 kg\/m<jats:sup>2<\/jats:sup>. The mean annual prevalence of severe exacerbations was 20.1%, and 48.4% of patients experienced \u22651 severe exacerbation during the 5-year study period. As the number of severe exacerbations increased, the interval between successive exacerbations decreased. A statistically significant decrease in mean (SD) FEV<jats:sub>1<\/jats:sub> from baseline to post-baseline was observed in patients with \u22651 severe exacerbation (1.23 (0.51) to 1.13 (0.52) L; p=0.0000). Mean BEC was 0.198 x10<jats:sup>9<\/jats:sup> cells\/L, with 64.7% of patients having a BEC \u22650.1 x10<jats:sup>9<\/jats:sup>\u2009cells\/L and 21.3% having a BEC \u22650.3 x10<jats:sup>9<\/jats:sup>\u2009cells\/L. The most common comorbidity was hypertension (58.3%). An increasing number of severe exacerbations per year was associated with greater HCRU.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>The findings presented here indicate that effective treatment strategies to prevent severe exacerbations in patients with COPD remain a significant unmet need in low-income and middle-income countries.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2023-002101","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T13:00:23Z","timestamp":1713445223000},"page":"e002101","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["Rate of severe exacerbations, healthcare resource utilisation and clinical outcomes in patients with COPD in low-income and middle-income countries: results from the EXACOS International Study"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9399-5275","authenticated-orcid":false,"given":"Rodrigo Abensur","family":"Athanazio","sequence":"first","affiliation":[{"name":"Pulmonology Division, Heart Institute-InCor-Clinical Hospital, Faculty of Medicine, Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bernal Villada","sequence":"additional","affiliation":[{"name":"Respiratory & Immunology, AstraZeneca, Bogota, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey N","family":"Avdeev","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Chien","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Ram\u00edrez-Venegas","sequence":"additional","affiliation":[{"name":"Tobacco Smoking and COPD Research Department, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn","family":"Sivori","sequence":"additional","affiliation":[{"name":"Pneumology Unit, Dr J M Ramos Mej\u00eda Pulmonology University Center, Faculty of Medicine, University of Buenos Aires, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Dreyse","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Critical Care Center, Cl\u00ednica Las Condes and School of Medicine Universidad Finis Terrae, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Pacheco","sequence":"additional","affiliation":[{"name":"Internal Medicine Research Group, Universidad Tecnol\u00f3gica de Pereira, Pereira, Colombia"},{"name":"Fundaci\u00f3n Universitaria Visi\u00f3n de las Am\u00e9ricas y Respiremos Unidad de Neumolog\u00eda, Pereira, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin Kit","family":"Man","sequence":"additional","affiliation":[{"name":"Department of Medicine and Geriatrics, Department of Medicine and Geriatrics, Tuen Mun Hospital, Hong Kong Special Administrative Region (HKSAR), Tuen Mun, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Noriega-Aguirre","sequence":"additional","affiliation":[{"name":"Center for Diagnosis and Treatment of Respiratory Diseases (CEDITER), Panama City, Panama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Farouk","sequence":"additional","affiliation":[{"name":"Respiratory & Immunology, AstraZeneca, Dubai, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,4,18]]},"reference":[{"key":"2025083110335662000_11.1.e002101.1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD) . Global strategy for prevention, diagnosis and management of COPD: 2024 report. Available: https:\/\/goldcopd.org\/2024-gold-report\/ [Accessed 14 Jan 2024]."},{"key":"2025083110335662000_11.1.e002101.2","first-page":"400","article-title":"The current landscape of COPD-related clinical trials registered on the world health organization's International clinical trials Registry platform: a comprehensive analysis of study characteristics and publication status","volume":"10","author":"Xu","year":"2023","journal-title":"Chronic Obstr Pulm Dis"},{"key":"2025083110335662000_11.1.e002101.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2020.05.002"},{"key":"2025083110335662000_11.1.e002101.4","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00052705"},{"key":"2025083110335662000_11.1.e002101.5","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.154.3.8810608"},{"key":"2025083110335662000_11.1.e002101.6","doi-asserted-by":"crossref","first-page":"107010","DOI":"10.1016\/j.rmed.2022.107010","article-title":"Clinical and microbiological characteristics and inflammatory profile during an exacerbation of COPD due to biomass exposure. A comparison with COPD due to tobacco exposure","volume":"204","author":"Sansores","year":"2022","journal-title":"Respir Med"},{"key":"2025083110335662000_11.1.e002101.7","doi-asserted-by":"crossref","DOI":"10.1038\/s41533-019-0117-y","article-title":"COPD\u2019s early origins in low-and-middle income countries: what are the implications of a false start","volume":"29","author":"Brakema","year":"2019","journal-title":"NPJ Prim Care Respir Med"},{"key":"2025083110335662000_11.1.e002101.8","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20032294","article-title":"Early origins of chronic obstructive pulmonary disease: prenatal and early life risk factors","volume":"20","author":"Deolmi","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"2025083110335662000_11.1.e002101.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60446-3"},{"key":"2025083110335662000_11.1.e002101.10","doi-asserted-by":"publisher","DOI":"10.1177\/1753465813479428"},{"key":"2025083110335662000_11.1.e002101.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1513737"},{"key":"2025083110335662000_11.1.e002101.12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-3060"},{"key":"2025083110335662000_11.1.e002101.13","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202005-1990OC"},{"key":"2025083110335662000_11.1.e002101.14","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201605-1014OC"},{"key":"2025083110335662000_11.1.e002101.15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.rmed.2017.04.013","article-title":"Effect of a single exacerbation on decline in lung function in COPD","volume":"128","author":"Halpin","year":"2017","journal-title":"Respir Med"},{"key":"2025083110335662000_11.1.e002101.16","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-018-0944-3","article-title":"Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial","volume":"19","author":"Watz","year":"2018","journal-title":"Respir Res"},{"key":"2025083110335662000_11.1.e002101.17","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.10.847"},{"key":"2025083110335662000_11.1.e002101.18","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.5.9709032"},{"key":"2025083110335662000_11.1.e002101.19","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2003.008730"},{"key":"2025083110335662000_11.1.e002101.20","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-11-181","article-title":"Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease","volume":"11","author":"Wedzicha","year":"2013","journal-title":"BMC Med"},{"key":"2025083110335662000_11.1.e002101.21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006171","article-title":"Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study","volume":"4","author":"M\u00fcllerov\u00e1","year":"2014","journal-title":"BMJ Open"},{"key":"2025083110335662000_11.1.e002101.22","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201710-2029OC"},{"key":"2025083110335662000_11.1.e002101.23","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S346591"},{"key":"2025083110335662000_11.1.e002101.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909883"},{"key":"2025083110335662000_11.1.e002101.25","unstructured":"World Health Organization . Chronic obstructive pulmonary disease (COPD). Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chronic-obstructive-pulmonary-disease-(copd) [Accessed 27 Mar 2023]."},{"key":"2025083110335662000_11.1.e002101.26","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00043710"},{"key":"2025083110335662000_11.1.e002101.27","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.040527"},{"key":"2025083110335662000_11.1.e002101.28","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.5.1449"},{"key":"2025083110335662000_11.1.e002101.29","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2011-201518"},{"key":"2025083110335662000_11.1.e002101.30","first-page":"952","article-title":"Surveillance for respiratory hazards in the occupational setting [American Thoracic society]","volume":"126","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"2025083110335662000_11.1.e002101.31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S2213-2600(15)00157-5","article-title":"Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data","volume":"3","author":"Soriano","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2025083110335662000_11.1.e002101.32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085540","article-title":"Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care","volume":"9","author":"M\u00fcllerov\u00e1","year":"2014","journal-title":"PLoS One"},{"key":"2025083110335662000_11.1.e002101.33","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-019-1255-z","article-title":"The socioeconomic burden of chronic lung disease in low-resource settings across the globe - an observational FRESH AIR study","volume":"20","author":"Brakema","year":"2019","journal-title":"Respir Res"},{"key":"2025083110335662000_11.1.e002101.34","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2466-14-112","article-title":"COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils","volume":"14","author":"Eltboli","year":"2014","journal-title":"BMC Pulm Med"},{"key":"2025083110335662000_11.1.e002101.35","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00072105"},{"key":"2025083110335662000_11.1.e002101.36","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.158.5.9804028"},{"key":"2025083110335662000_11.1.e002101.37","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S152291"},{"key":"2025083110335662000_11.1.e002101.38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-2600(18)30006-7","article-title":"Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials","volume":"6","author":"Bafadhel","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2025083110335662000_11.1.e002101.39","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-019-1268-7","article-title":"Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis","volume":"21","author":"Harries","year":"2020","journal-title":"Respir Res"},{"key":"2025083110335662000_11.1.e002101.40","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201502-0235LE"},{"key":"2025083110335662000_11.1.e002101.41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2025083110335662000_11.1.e002101.42","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2016-000151","article-title":"Effect of inhaled corticosteroids on blood eosinophil count in steroid-naive patients with COPD","volume":"3","author":"Kreindler","year":"2016","journal-title":"BMJ Open Respir Res"},{"key":"2025083110335662000_11.1.e002101.43","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2147\/COPD.S100338","article-title":"Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD","volume":"11","author":"Negewo","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025083110335662000_11.1.e002101.44","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201509-1869OC"},{"key":"2025083110335662000_11.1.e002101.45","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2213-2600(16)00100-4","article-title":"Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial","volume":"4","author":"Watz","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2025083110335662000_11.1.e002101.46","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/15412555.2018.1509951","article-title":"Obesity in COPD: comorbidities with practical consequences?","volume":"15","author":"Zewari","year":"2018","journal-title":"COPD"},{"key":"2025083110335662000_11.1.e002101.47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105220","article-title":"Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease","volume":"9","author":"Garc\u00eda-Rio","year":"2014","journal-title":"PLoS One"},{"key":"2025083110335662000_11.1.e002101.48","first-page":"1685","article-title":"Distribution of body mass index among subjects with COPD in the Middle East and North Africa region: data from the BREATHE study","volume":"10","author":"Koniski","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025083110335662000_11.1.e002101.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.12.025"},{"key":"2025083110335662000_11.1.e002101.50","doi-asserted-by":"publisher","DOI":"10.1159\/000281880"},{"key":"2025083110335662000_11.1.e002101.51","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200709-148ET"},{"key":"2025083110335662000_11.1.e002101.52","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp17X690605"},{"key":"2025083110335662000_11.1.e002101.53","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.128082"},{"key":"2025083110335662000_11.1.e002101.54","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2296-14-11","article-title":"Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional study","volume":"14","author":"Garc\u00eda-Olmos","year":"2013","journal-title":"BMC Fam Pract"},{"key":"2025083110335662000_11.1.e002101.55","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006836","article-title":"Prevalence of comorbidities in chronic obstructive pulmonary disease patients: a meta-analysis","volume":"96","author":"Yin","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"2025083110335662000_11.1.e002101.56","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2847"},{"key":"2025083110335662000_11.1.e002101.57","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S77562"},{"key":"2025083110335662000_11.1.e002101.58","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2466-13-51","article-title":"Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study","volume":"13","author":"Kim","year":"2013","journal-title":"BMC Pulm Med"},{"key":"2025083110335662000_11.1.e002101.59","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201003-0472OC"},{"key":"2025083110335662000_11.1.e002101.60","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0342"},{"key":"2025083110335662000_11.1.e002101.61","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2013-000002","article-title":"Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction","volume":"1","author":"Andell","year":"2014","journal-title":"Open Heart"},{"key":"2025083110335662000_11.1.e002101.62","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00012408"},{"key":"2025083110335662000_11.1.e002101.63","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201201-0034OC"},{"key":"2025083110335662000_11.1.e002101.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.05.001"},{"key":"2025083110335662000_11.1.e002101.65","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(98)90310-9"},{"key":"2025083110335662000_11.1.e002101.66","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.072348"},{"key":"2025083110335662000_11.1.e002101.67","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000196687","article-title":"Survival and cause of death among elderly chronic obstructive pulmonary disease patients after first admission to hospital","volume":"64","author":"Vilkman","year":"1997","journal-title":"Respiration"},{"key":"2025083110335662000_11.1.e002101.68","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/15412555.2010.510160","article-title":"Mortality in COPD: causes, risk factors, and prevention","volume":"7","author":"Berry","year":"2010","journal-title":"COPD"},{"key":"2025083110335662000_11.1.e002101.69","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/resp.13620","article-title":"Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD","volume":"24","author":"Reilev","year":"2019","journal-title":"Respirology"},{"key":"2025083110335662000_11.1.e002101.70","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201711-2239OC"},{"key":"2025083110335662000_11.1.e002101.71","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201505-0962OC"},{"key":"2025083110335662000_11.1.e002101.72","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1513\/AnnalsATS.201710-815OC","article-title":"Myocardial infarction and ischemic stroke after exacerbations of chronic obstructive pulmonary disease","volume":"15","author":"Rothnie","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"2025083110335662000_11.1.e002101.73","doi-asserted-by":"crossref","unstructured":"L\u00f8kke A , Hilberg O , Lange P , et al . Exacerbations predict severe cardiovascular events in patients with COPD and stable cardiovascular disease-a nationwide, population-based cohort study. Int J Chron Obstruct Pulmon Dis 2023;18:419\u201329.","DOI":"10.2147\/COPD.S396790"},{"key":"2025083110335662000_11.1.e002101.74","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11739-011-0636-1","article-title":"Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patients","volume":"8","author":"Polosa","year":"2013","journal-title":"Intern Emerg Med"},{"key":"2025083110335662000_11.1.e002101.75","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.05.026"},{"key":"2025083110335662000_11.1.e002101.76","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613998"},{"key":"2025083110335662000_11.1.e002101.77","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.18.1477"},{"key":"2025083110335662000_11.1.e002101.78","doi-asserted-by":"crossref","DOI":"10.1177\/1753465817750524","article-title":"Defining the relationship between COPD and CVD: what are the implications for clinical practice?","volume":"12","author":"Morgan","year":"2018","journal-title":"Ther Adv Respir Dis"},{"key":"2025083110335662000_11.1.e002101.79","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2015.07.012"},{"key":"2025083110335662000_11.1.e002101.80","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S154097"},{"key":"2025083110335662000_11.1.e002101.81","doi-asserted-by":"crossref","DOI":"10.5688\/ajpe7218","article-title":"Cultural sensitivity and global pharmacy engagement in Latin America: Argentina, Brazil, Ecuador, Guatemala, and Mexico","volume":"83","author":"Haack","year":"2019","journal-title":"Am J Pharm Educ"},{"key":"2025083110335662000_11.1.e002101.82","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.chest.2022.06.033","article-title":"Clinical characteristics, treatment persistence, and outcomes among patients with COPD treated with single- or multiple-inhaler triple therapy: a retrospective analysis in Spain","volume":"162","author":"Alc\u00e1zar-Navarrete","year":"2022","journal-title":"Chest"},{"key":"2025083110335662000_11.1.e002101.83","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00950-2020","article-title":"INTREPID: Single- versus multiple-inhaler triple therapy for COPD in usual clinical practice","volume":"7","author":"Halpin","year":"2021","journal-title":"ERJ Open Res"},{"key":"2025083110335662000_11.1.e002101.84","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2022.106807"},{"key":"2025083110335662000_11.1.e002101.85","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/17571472.2010.11493315","article-title":"An overview of the healthcare system in Taiwan","volume":"3","author":"Wu","year":"2010","journal-title":"London J Prim Care (Abingdon)"},{"key":"2025083110335662000_11.1.e002101.86","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00194610"},{"key":"2025083110335662000_11.1.e002101.87","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/resp.13935","article-title":"Challenges faced in managing adult asthma: a perspective from Asian countries","volume":"25","author":"Dhar","year":"2020","journal-title":"Respirology"},{"key":"2025083110335662000_11.1.e002101.88","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kww085"},{"key":"2025083110335662000_11.1.e002101.89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2018.09.010","article-title":"Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013","volume":"144","author":"Oshagbemi","year":"2018","journal-title":"Respir Med"},{"key":"2025083110335662000_11.1.e002101.90","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/COPD.S3385","article-title":"Exacerbation rate, health status and mortality in COPD--a review of potential interventions","volume":"4","author":"Seemungal","year":"2009","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025083110335662000_11.1.e002101.91","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-0281"},{"key":"2025083110335662000_11.1.e002101.92","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2147\/COPD.S54475","article-title":"The causes and consequences of seasonal variation in COPD exacerbations","volume":"9","author":"Donaldson","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025083110335662000_11.1.e002101.93","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01501-2016","article-title":"Colder temperature is associated with increased COPD morbidity","volume":"49","author":"McCormack","year":"2017","journal-title":"Eur Respir J"},{"key":"2025083110335662000_11.1.e002101.94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057066","article-title":"The effect of cold temperature on increased exacerbation of chronic obstructive pulmonary disease: a nationwide study","volume":"8","author":"Tseng","year":"2013","journal-title":"PLoS One"},{"key":"2025083110335662000_11.1.e002101.95","first-page":"703","article-title":"Pharmacological management and prevention of exacerbations of chronic obstructive pulmonary disease in hospitalized patients","volume":"41","author":"Dixit","year":"2016","journal-title":"P T"},{"key":"2025083110335662000_11.1.e002101.96","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.2147\/COPD.S139470","article-title":"Impact and prevention of severe exacerbations of COPD: a review of the evidence","volume":"12","author":"Halpin","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025083110335662000_11.1.e002101.97","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-1676"},{"key":"2025083110335662000_11.1.e002101.98","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19031749","article-title":"Changes in access to health services during the COVID-19 pandemic: a scoping review","volume":"19","author":"Pujolar","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2025083110335662000_11.1.e002101.99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255659","article-title":"Reduction in hospitalised COPD exacerbations during COVID-19: a systematic review and meta-analysis","volume":"16","author":"Alqahtani","year":"2021","journal-title":"PLoS One"},{"key":"2025083110335662000_11.1.e002101.100","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2015.36.3812"},{"key":"2025083110335662000_11.1.e002101.101","doi-asserted-by":"publisher","DOI":"10.3109\/15412555.2010.481697"},{"key":"2025083110335662000_11.1.e002101.102","doi-asserted-by":"crossref","DOI":"10.1186\/s13561-021-00329-9","article-title":"Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review","volume":"11","author":"Guti\u00e9rrez Villegas","year":"2021","journal-title":"Health Econ Rev"},{"key":"2025083110335662000_11.1.e002101.103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152618","article-title":"Continuing to Confront COPD International Patient Survey: economic impact of COPD in 12 countries","volume":"11","author":"Foo","year":"2016","journal-title":"PLoS One"},{"key":"2025083110335662000_11.1.e002101.104","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.5588\/ijtld.22.0544","article-title":"Key messages and partnerships to raise awareness and improve outcomes for people with asthma and COPD in low- and middle-income countries","volume":"26","author":"Rylance","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025083110335662000_11.1.e002101.105","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.chest.2020.09.260","article-title":"Gaps in COPD guidelines of low- and middle-income countries: a systematic scoping review","volume":"159","author":"Tabyshova","year":"2021","journal-title":"Chest"},{"key":"2025083110335662000_11.1.e002101.106","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1513\/AnnalsATS.202103-284ST","article-title":"Challenges in the implementation of chronic obstructive pulmonary disease guidelines in low- and middle-income countries: an official American Thoracic Society workshop report","volume":"18","author":"Hurst","year":"2021","journal-title":"Annals ATS"},{"key":"2025083110335662000_11.1.e002101.107","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.5588\/ijtld.22.0270","article-title":"Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries","volume":"26","author":"Stolbrink","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025083110335662000_11.1.e002101.108","doi-asserted-by":"crossref","first-page":"e1423","DOI":"10.1016\/S2214-109X(22)00330-8","article-title":"The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review","volume":"10","author":"Stolbrink","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2025083110335662000_11.1.e002101.109","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202110-2441OC"},{"key":"2025083110335662000_11.1.e002101.110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152266","article-title":"COPD underdiagnosis and misdiagnosis in a high-risk primary care population in four Latin American countries. A key to enhance disease diagnosis: the PUMA study","volume":"11","author":"Casas Herrera","year":"2016","journal-title":"PLoS One"},{"key":"2025083110335662000_11.1.e002101.111","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-2535"},{"key":"2025083110335662000_11.1.e002101.112","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00117413"},{"key":"2025083110335662000_11.1.e002101.113","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2013.07.007"},{"key":"2025083110335662000_11.1.e002101.114","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/RMHP.S168399","article-title":"The evolving Semashko model of primary health care: the case of the Russian Federation","volume":"11","author":"Sheiman","year":"2018","journal-title":"Risk Manag Healthc Policy"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2023-002101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:34:12Z","timestamp":1756661652000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2023-002101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":114,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,4,18]]},"published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1136\/bmjresp-2023-002101"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2023-002101","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]}}}